233 related articles for article (PubMed ID: 29712497)
1. First-trimester metabolomic prediction of stillbirth.
Bahado-Singh RO; Syngelaki A; Mandal R; Han B; Li L; Bjorndahl TC; Wang N; Maulik D; Dong E; Turkoglu O; Tseng CL; Zeb A; Redman M; Wishart DS; Nicolaides KH
J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3435-3441. PubMed ID: 29712497
[No Abstract] [Full Text] [Related]
2. Prediction of stillbirth from biochemical and biophysical markers at 11-13 weeks.
Mastrodima S; Akolekar R; Yerlikaya G; Tzelepis T; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Nov; 48(5):613-617. PubMed ID: 27561595
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic prediction of fetal congenital heart defect in the first trimester.
Bahado-Singh RO; Ertl R; Mandal R; Bjorndahl TC; Syngelaki A; Han B; Dong E; Liu PB; Alpay-Savasan Z; Wishart DS; Nicolaides KH
Am J Obstet Gynecol; 2014 Sep; 211(3):240.e1-240.e14. PubMed ID: 24704061
[TBL] [Abstract][Full Text] [Related]
4. Prediction of stillbirth from placental growth factor at 11-13 weeks.
Akolekar R; Machuca M; Mendes M; Paschos V; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Nov; 48(5):618-623. PubMed ID: 27854388
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics and first-trimester prediction of early-onset preeclampsia.
Bahado-Singh RO; Akolekar R; Mandal R; Dong E; Xia J; Kruger M; Wishart DS; Nicolaides K
J Matern Fetal Neonatal Med; 2012 Oct; 25(10):1840-7. PubMed ID: 22494326
[TBL] [Abstract][Full Text] [Related]
6. Validation of metabolomic models for prediction of early-onset preeclampsia.
Bahado-Singh RO; Syngelaki A; Akolekar R; Mandal R; Bjondahl TC; Han B; Dong E; Bauer S; Alpay-Savasan Z; Graham S; Turkoglu O; Wishart DS; Nicolaides KH
Am J Obstet Gynecol; 2015 Oct; 213(4):530.e1-530.e10. PubMed ID: 26116099
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic prediction of severe maternal and newborn complications in preeclampsia.
Idler J; Turkoglu O; Yilmaz A; Ashrafi N; Szymanska M; Ustun I; Patek K; Whitten A; Graham SF; Bahado-Singh RO
Metabolomics; 2024 May; 20(3):56. PubMed ID: 38762675
[TBL] [Abstract][Full Text] [Related]
8. Studies on Novel Diagnostic and Predictive Biomarkers of Intrahepatic Cholestasis of Pregnancy Through Metabolomics and Proteomics.
Dong R; Ye N; Zhao S; Wang G; Zhang Y; Wang T; Zou P; Wang J; Yao T; Chen M; Zhou C; Zhang T; Luo L
Front Immunol; 2021; 12():733225. PubMed ID: 34721396
[TBL] [Abstract][Full Text] [Related]
9. First-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics Approach.
Koster MP; Vreeken RJ; Harms AC; Dane AD; Kuc S; Schielen PC; Hankemeier T; Berger R; Visser GH; Pennings JL
Dis Markers; 2015; 2015():857108. PubMed ID: 26146448
[TBL] [Abstract][Full Text] [Related]
10. Potential first trimester metabolomic biomarkers of abnormal birth weight in healthy pregnancies.
Ciborowski M; Zbucka-Kretowska M; Bomba-Opon D; Wielgos M; Brawura-Biskupski-Samaha R; Pierzynski P; Szmitkowski M; Wolczynski S; Lipinska D; Citko A; Bauer W; Gorska M; Kretowski A
Prenat Diagn; 2014 Sep; 34(9):870-7. PubMed ID: 24733416
[TBL] [Abstract][Full Text] [Related]
11. First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study.
Austdal M; Tangerås LH; Skråstad RB; Salvesen K; Austgulen R; Iversen AC; Bathen TF
Int J Mol Sci; 2015 Sep; 16(9):21520-38. PubMed ID: 26370975
[TBL] [Abstract][Full Text] [Related]
12. Untargeted analysis of first trimester serum to reveal biomarkers of pregnancy complications: a case-control discovery phase study.
Harville EW; Li YY; Pan K; McRitchie S; Pathmasiri W; Sumner S
Sci Rep; 2021 Feb; 11(1):3468. PubMed ID: 33568690
[TBL] [Abstract][Full Text] [Related]
13. Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics.
Yu M; Sun S; Yu J; Du F; Zhang S; Yang W; Xiao J; Xie B
J Proteome Res; 2018 Oct; 17(10):3517-3525. PubMed ID: 30207476
[TBL] [Abstract][Full Text] [Related]
14. Prediction of stillbirth from placental growth factor at 19-24 weeks.
Aupont JE; Akolekar R; Illian A; Neonakis S; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Nov; 48(5):631-635. PubMed ID: 27854395
[TBL] [Abstract][Full Text] [Related]
15. Maternal Early Pregnancy Serum Metabolomics Profile and Abnormal Vaginal Bleeding as Predictors of Placental Abruption: A Prospective Study.
Gelaye B; Sumner SJ; McRitchie S; Carlson JE; Ananth CV; Enquobahrie DA; Qiu C; Sorensen TK; Williams MA
PLoS One; 2016; 11(6):e0156755. PubMed ID: 27300725
[TBL] [Abstract][Full Text] [Related]
16. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
17. Utility of metabolic profiling of serum in the diagnosis of pregnancy complications.
Powell KL; Carrozzi A; Stephens AS; Tasevski V; Morris JM; Ashton AW; Dona AC
Placenta; 2018 Jun; 66():65-73. PubMed ID: 29884304
[TBL] [Abstract][Full Text] [Related]
18. First-trimester placentation and the risk of antepartum stillbirth.
Smith GC; Crossley JA; Aitken DA; Pell JP; Cameron AD; Connor JM; Dobbie R
JAMA; 2004 Nov; 292(18):2249-54. PubMed ID: 15536112
[TBL] [Abstract][Full Text] [Related]
19. First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study.
Odibo AO; Goetzinger KR; Odibo L; Cahill AG; Macones GA; Nelson DM; Dietzen DJ
Prenat Diagn; 2011 Oct; 31(10):990-4. PubMed ID: 21744367
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
